Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion type Assertion NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_head.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion description "[To determine whether a specifically designed bispecific (Bcl-2/Bcl-xL) antisense oligonucleotide (ASO) induces apoptosis and enhances chemosensitivity in human prostate cancer LNCaP cells, as Bcl-2 and Bcl-xL are both anti-apoptotic genes associated with treatment resistance and tumour progression in many malignancies, including prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_provenance.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion evidence source_evidence_literature NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_provenance.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion SIO_000772 16686729 NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_provenance.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion wasDerivedFrom befree-2016 NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_provenance.
- NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_assertion wasGeneratedBy ECO_0000203 NP549059.RAYXud11iNy3cRRPFo6qTWiVffUveXF_biGJkyo5uxBQY130_provenance.